XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,662,772 | +11.7% | 48,676 | +25.9% | 0.04% | -10.6% |
| Q2 2023 | $1,489,026 | -34.4% | 38,676 | -39.0% | 0.05% | -32.9% |
| Q1 2023 | $2,268,764 | -99.9% | 63,391 | +16.9% | 0.07% | +89.2% |
| Q3 2022 | $1,957,000,000 | -33.1% | 54,208 | -43.7% | 0.04% | -14.0% |
| Q2 2022 | $2,927,000,000 | – | 96,208 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $57,577,000 | 9.26% |
| GREAT POINT PARTNERS LLC | 850,000 | $30,685,000 | 7.39% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $9,837,000 | 4.24% |
| DAFNA Capital Management LLC | 375,223 | $13,546,000 | 3.64% |
| Redmile Group, LLC | 2,370,614 | $85,579,000 | 3.32% |
| Avoro Capital Advisors LLC | 4,900,000 | $176,890,000 | 3.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,992 | $8,880,000 | 3.00% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,129,000 | 2.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,504,020 | $162,595,000 | 2.46% |
| Parkman Healthcare Partners LLC | 222,597 | $8,036,000 | 2.28% |